Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in the Netherlands
Background: Due to the lack of solid evidence for treatment benefit of Sentinel Lymph Node Biopsy (SLNB) as part of loco-regional surgical treatment of non-distant metastatic melanoma, there might be variation in surgical treatment strategies in the Netherlands. The objective of the current study was to assess differences in the performance of SLNB, in geographical regions in the Netherlands, of non-distant metastatic melanoma patients (American Joint Committee on Cancer (AJCC) stage I-III). Materials and methods: A total of 28 550 melanoma patients, diagnosed between 2005 and 2013, were inclu... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2017 |
Reihe/Periodikum: | Verstijnen , J , Damude , S , Hoekstra , H J , Kruijff , S , ten Tije , A J , Louwman , W J , Bastiaannet , E & Stuiver , M M 2017 , ' Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in the Netherlands ' , Surgical oncology-Oxford , vol. 26 , no. 4 , pp. 431-437 . https://doi.org/10.1016/j.suronc.2017.08.006 |
Schlagwörter: | Melanoma / Sentinel Lymph Node Biopsy / Practice variation / STAGE-III MELANOMA / PROGNOSTIC-FACTOR / CUTANEOUS MELANOMA / DISSECTION / SURVIVAL / IPILIMUMAB / EUROPE / TRENDS / TRIAL / AGE |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26826555 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/d02555dc-f05d-452a-bcc2-b7bf59d4db4c |